Effects of sodium-glucose cotransporter-2 inhibitors on inflammatory skin diseases in patients with type 2 diabetes.

Ma, Kevin Sheng-Kai; Tsai, Serena Yun-Chen; Holt, Allison; Chen, Steven T.

Afiliação

Ma KS; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Center for Global Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: kevinskma1@gmail.com.
Tsai SY; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.
Holt A; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Chen ST; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts. Electronic address: stchen@mgb.org.

J Am Acad Dermatol ; 2024 Jun 10.

Article em En | MEDLINE | ID: mdl-38866183